In a move to consolidate corporate brand identity, MedeAnalytics, a leading provider of healthcare performance management solutions, today announced that the name of its London-based U.K. subsidiary Mede International Ltd. has been changed to MedeAnalytics International Ltd., with MedeAnalytics to serve as its brand.
“This change completes the company’s brand transformation process and reflects our commitment—both in the U.S. and the U.K.—to improve financial, operational and clinical outcomes for our clients,” said MedeAnalytics Chief Executive Officer Mike Gallagher. “It underscores the fact that MedeAnalytics’ clients experience the same high level of customer focus, innovative problem solving, and delivery of solutions, no matter where they are located.”
MedeAnalytics International partners with the Healthcare Financial Management Association (HFMA) in the U.K. in delivering a national performance network for acute trusts and strategic health authority (SHA)-primary care trust (PCT) cohorts supporting the QIPP (quality, innovation, productivity and prevention) agenda. Recently selected by the NHS Information Centre to join its national framework under the production stream for national health statistics, MedeAnalytics International has a significant client base, spanning foundation trusts, teaching hospitals, PCTs and SHAs.
UK's drug payment disclosure system fails to protect patients and public trust